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Tumor protein D54 defines a new class of
intracellular transport vesicles
Gabrielle Larocque, Penelope J. La-Borde, Nicholas I. Clarke, Nicholas J. Carter, and Stephen J. Royle
Transport of proteins and lipids from one membrane compartment to another is via intracellular vesicles. We investigated the
function of tumor protein D54 (TPD54/TPD52L2) and found that TPD54 was involved in multiple membrane trafficking
pathways: anterograde traffic, recycling, and Golgi integrity. To understand how TPD54 controls these diverse functions, we
used an inducible method to reroute TPD54 to mitochondria. Surprisingly, this manipulation resulted in the capture of many
small vesicles (30 nm diameter) at the mitochondrial surface. Super-resolution imaging confirmed the presence of similarly
sized TPD54-positive structures under normal conditions. It appears that TPD54 defines a new class of transport vesicle,
which we term intracellular nanovesicles (INVs). INVs meet three criteria for functionality. They contain specific cargo, they
have certain R-SNAREs for fusion, and they are endowed with a variety of Rab GTPases (16 out of 43 tested). The molecular
heterogeneity of INVs and the diverse functions of TPD54 suggest that INVs have various membrane origins and a number of
destinations. We propose that INVs are a generic class of transport vesicle that transfer cargo between these varied locations.
Introduction
Eukaryotic cells are by definition compartmentalized: they
contain organelles and membrane-bound domains that have
distinct identities. Vesicle transport between these locations is
tightly regulated to maintain these identities, yet allows ex-
change of specific materials. There are several types of vesicular
carrier described so far that are classified according to mor-
phology or location. Well-characterized examples include clathrin-
coated vesicles (50–100 nm diameter) formed at the plasma
membrane (PM) or TGN, COPII-coated vesicles (60–70 nm) orig-
inating at the ER, and intra-Golgi transport vesicles (70–90 nm;
Vigers et al., 1986; Balch et al., 1994; Orci et al., 2000).Whether cell
biologists have a complete inventory of vesicular carriers is an
interesting open question.
In humans, there are four tumor protein D52-like proteins
(TPD52-like proteins; TPD52, TPD53/TPD52L1, TPD54/TPD52L2,
and TPD55/TPD52L3), some of which have been associated with
membrane trafficking, but the cell biological roles of the family
are not well characterized. TPD52-like proteins are short
(140–224 residues), have 50% identity, and each contain a coiled-
coil domain through which they can homodimerize or hetero-
dimerize (Byrne et al., 1998). All are ubiquitously expressed with
the exception of TPD55, which is restricted to testis (Cao et al.,
2006). TPD52 was the first of the family to be identified due to
its overexpression in cancer, and it is still the best studied.
However, all members have been found to be overexpressed in a
series of cancers (Cao et al., 2006; Byrne et al., 1995, 1998;
Nourse et al., 1998). Overexpression of TPD52 correlates with
poor prognosis in breast cancer patients, and in cell models,
TPD52 overexpression promotes proliferation and invasion
(Byrne et al., 2010, 1996; Li et al., 2017; Dasari et al., 2017).
Rather disparate membrane trafficking functions have been
reported for TPD52 and TPD53. First, TPD52 is involved in se-
cretion in pancreatic acinar cells (Thomas et al., 2004, 2010;
Messenger et al., 2013) and potentially at synapses (Biesemann
et al., 2014). Second, membrane trafficking proteins bind to
TPD52, such as the endocytic protein Rab5c (Shahheydari et al.,
2014), and the transcytotic protein MAL2 (Wilson et al., 2001).
Third, TPD52 has a role in lipid droplet biogenesis at the Golgi
(Kamili et al., 2015; Chen et al., 2019). Finally, a role in mem-
brane fusion was proposed for TPD53 (Proux-Gillardeaux et al.,
2003). By contrast, the potential functions of TPD54 remain
unexplored.
What is striking about TPD54 is its sheer abundance in cells.
Previous quantitative proteomic analyses revealed that TPD54 is
one of the most abundant proteins in HeLa cells, ranked 180th
out of 8,804 (Hein et al., 2015; Kulak et al., 2014). There are an
estimated 3.3 × 106 copies of TPD54 per HeLa cell (2.7 µM),
whereas abundant membrane traffic proteins such as clathrin
light chain A or β2 subunit of AP2 total 2.2 × 106 or 1.0 × 105
copies (1.8 µM or 0.4 µM), respectively (Hein et al., 2015).
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Despite its abundance, there are virtually no published data on
the cell biology of TPD54. Due to sequence similarity and het-
erodimerization properties, we hypothesized that TPD54, like
the other members of the family, would also be involved in
membrane trafficking. We set out to investigate the cell biology
of TPD54 and found that it defines a novel class of intracellular
transport vesicle, which we have termed intracellular nano-
vesicles (INVs). These vesicles are small, functional, and mo-
lecularly diverse, suggesting that they mediate transport
throughout the membrane traffic network.
Results
TPD54 is a membrane trafficking protein
To investigate the subcellular localization of TPD54,we generated
a cell line where TPD54 was tagged at its endogenous locus with
monomeric GFP (Fig. 1 and Fig. S1). GFP-TPD54 fluorescence was
apparently diffuse in the cytoplasm, but was also seen at the Golgi
apparatus, marked with GalT-mCherry, and on endosomes,
marked by APPL1 and OCRL1. It also partially overlaps with
various membrane trafficking proteins, such as clathrin light
chain A and the R-SNARE VAMP2 (Fig. 1 A). A similar pattern
was seen by overexpression of GFP-, mCherry-, or FLAG-tagged
TPD54 in parental cells (Fig. S2). These observations suggest that
TPD54 is a protein associated with membrane trafficking.
As a next step to characterizing TPD54, we investigated the
binding partners of TPD54. To do so, we performed an immu-
noprecipitation of GFP-tagged TPD54 from HeLa cell lysates and
analyzed coprecipitating proteins by mass spectrometry (Fig. 1
B). We found that two other members of the TPD52-like family,
TPD52 and TPD53, were significantly enriched in the TPD54
samples versus control. TPD52, TPD53, and TPD54 have been
reported to heterodimerize (Byrne et al., 1998), which suggested
that this analysis was able to detect binding partners of TPD54.
Among the other significant hits, we found the Rab GTPases
Rab14, Rab2a, and Rab5c. Rab14 has been identified as a regulator
of the transport between the Golgi apparatus and early endo-
somes (Junutula et al., 2004), as well as from the Golgi apparatus
to the PM (Kitt et al., 2008). Rab2a is on the ER-to-Golgi pathway
(Tisdale et al., 1992), and Rab5c is found on the endocytic path-
way (Bucci et al., 1995). Taken together, the results confirm that
TPD54 is a protein involved in membrane trafficking.
TPD54 is involved in multiple membrane trafficking pathways
To investigate potential functions of TPD54, we sought to
identify trafficking defects caused by the loss of TPD54. Using
RNAi to deplete TPD54 in HeLa cells, we first assessed the
transport of cargoes from the ER to the Golgi apparatus, and
from the Golgi to the PM with the RUSH (retention using se-
lective hooks) system (Boncompain et al., 2012). Briefly, the
RUSH system allows the synchronous release of a reporter (here,
GFP-tagged E-cadherin with a streptavidin-binding domain)
from an ER-localized hook (here, streptavidin fused to a KDEL
amino acid motif) by addition of biotin. After release, EGFP–E-
cadherin is transported from the ER to the PM, via the Golgi
apparatus. In control cells, the reporter reached maximal inten-
sity at the Golgi between 14 and 28 min after release and then left
the Golgi for the PM (Fig. 2, A and B; and Video 1). By contrast,
TPD54-depleted cells had obviously delayed kinetics (Fig. 2, A
and B; and Video 2). We quantified the fluorescence of the re-
porter at the Golgi and expressed it as a fraction of the total cell
fluorescence. The resulting data were best described by a logistic
function representing ER-to-Golgi transport and a line fit to de-
scribe Golgi-to-PM (Fig. 2 B; see Materials and methods). Similar
retardation of traffic was seen with three siRNAs to TPD54
(Fig. 2, C and D). This automated procedure allowed us to find the
t1/2 for ER-to-Golgi and ER-to-PM transport and also infer the
Golgi transport time as the difference between these times
(Fig. 2, E–G). The data suggest that TPD54-depleted cells have
delayed export of E-cadherin at all stages.
Figure 1. TPD54 is a membrane trafficking protein. (A) Representative confocal micrographs showing transiently expressed mCherry-tagged membrane
trafficking proteins of interest (POI) and endogenously tagged GFP-TPD54. Inset, 3× zoom. Scale bars, 10 µm, 1 µm (inset). (B) Volcano plot of a comparative
mass spectrometry analysis of GFP-TPD54 vs. GFP co-immunoprecipitation. Proteins enriched more than twofold in GFP-TPD54 samples compared with GFP
are shown in red or pink; those P < 0.05 are shown in blue or pink. nexp = 4. Note, glycogen debranching enzyme (3.7-fold increase, P = 1.09 × 10−8) is not
shown. Proteomic data and volcano plot calculations are available (Royle, 2019). IP, immunoprecipitation.
Larocque et al. Journal of Cell Biology 2
New small transport vesicles defined by TPD54 https://doi.org/10.1083/jcb.201812044
D
ow
nloaded from
 https://rupress.org/jcb/article-pdf/219/1/e201812044/840661/jcb_201812044.pdf by guest on 17 D
ecem
ber 2019
We alsowanted to know if TPD54was required for endocytosis
or cargo recycling since Rab5c was one of our mass spectrometry
hits (Fig. 1 B). To do so, we performed a transferrin uptake and
recycling assay in TPD54-depleted and control HeLa cells. The
internalization of transferrin was unchanged, but recycling to the
PM was slower in TPD54-depleted cells (Fig. 2 H). In these ex-
periments, the efficiency of the depletion was checked by West-
ern blot analysis, using α-tubulin as a loading control (Fig. 2 D).
In the RUSH experiments, we noticed that the Golgi appeared
dispersed as cargo moved through it (see Fig. 2 A). Therefore,
our third functional test was to assess the distribution of the
TGN using TGN46 as a marker. Depletion of TPD54 by RNAi
resulted in dispersion of the TGN (Fig. 3 A). Although knock-
down of TPD54 was good, as assessed by Western blot, the Golgi
dispersal phenotype was mild (Fig. 3 B). Next, we knocked out
the TPD54 gene in HeLa cells using CRISPR/Cas9 and recovered
two independent clones that had no detectable expression of
TPD54 (Fig. S3). We saw severe TGN dispersal in both clones
that lacked TPD54, compared with the parental cells (Fig. 3, C
and D). Importantly, normal TGN distribution could be rescued
Figure 2. TPD54-depleted cells have defective anterograde membrane traffic and cargo recycling. (A) Still confocal images of RUSH experiments. SBP-
EGFP–E-cadherin localization in control (siCtrl) and TPD54-depleted (siTPD54) HeLa cells at the indicated times (minutes and seconds) after biotin treatment.
Scale bar, 10 µm. (B) Single cell traces of the E-cadherin fluorescence ratio of a control (gray) or TPD54-depleted (blue) cell, fitted with a logistic function and a
line. (C) Normalized fraction of total E-cadherin fluorescence at the Golgi as a function of time in control (gray) or TPD54-depleted (colored) cells. Results from
three siRNAs are shown as indicated. Line and shaded area, mean ± SEM. ncell = 85 (siCtrl), 62 (siTPD54 #1), nexp = 2; ncell = 23 (siCtrl), 12 (siTPD54 #2), nexp = 1;
ncell = 43 (siCtrl), 20 (siTPD54 #3), nexp = 1. (D) Western blot to assess the depletion of TPD54 by RNAi for three siRNAs. The protein level of TPD54 and
α-tubulin (loading control) is shown. (E–G) Box plots showing the t1/2 of E-cadherin transport from ER-to-Golgi (E) and from ER-to-PM (F) in control and
TPD54-depleted cells. (G) The difference in t1/2 represents intra-Golgi transport. Dots represent individual cells, boxes show interquartile range, bars rep-
resents the median, and whiskers show 9th and 91st percentiles. The P values are from Student’s t test with Welch’s correction. ncell = 57−82, nexp = 2. (H) Plot
showing the uptake and recycling of transferrin in control and TPD54-depleted cells. Dots represent individual cells, lines represent the median value.Wilcoxon
rank test. **, P < 0.01. ncell = 77−160, nexp = 3.
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in each clone by reexpression of FLAG-tagged TPD54, but not by
expression of an unrelated protein containing a coiled-coil do-
main (FLAG-TACC3, Fig. 3 D). To our frustration, the Golgi
dispersal phenotype in both knockout clones disappeared with
repeated passaging, which might be explained by compensation
for the chronic loss of TPD54 in knockout cells. These experi-
ments confirm that the Golgi dispersal phenotype is specifically
due to loss of TPD54 and is not the result of off-target action.
Together, our results suggest that TPD54 operates in several
membrane trafficking pathways: (1) anterograde traffic, (2)
endosomal recycling, and (3) Golgi integrity.
Rerouting TPD54 to mitochondria changes
mitochondrial morphology
Knocksideways is a standard method to remove a protein from
its site of action to understand its normal function or study its
binding partners (Robinson et al., 2010). To do this, proteins
tagged with an FK506-binding protein (FKBP) domain can be
rerouted to MitoTrap, a mitochondrially targeted FRB domain,
by the addition of rapamycin. As expected, mCherry-FKBP-
TPD54, but not mCherry-TPD54, was efficiently rerouted to
mitochondria using this method (Fig. 4 A). The kinetics of re-
routing was reasonably fast, with TPD54 appearing at mito-
chondria 6 s after rapamycin (Fig. 4, B and C; and Video 3). The
increase in mitochondrial TPD54 was best fit by a single expo-
nential function (χ2 = 0.43, τ = 37.98 ± 0.38 s), while the loss in
cytoplasmic signal followed similar kinetics (τ = 47.52 ± 0.21 s;
Fig. 4 B). During our TPD54-rerouting experiments, we noticed
that once the rerouting was complete, mitochondrial morphol-
ogy became altered and the mitochondria began to aggregate
(Fig. 4 C).
Mitochondrial rerouting of TPD54 results in vesicle capture
To investigate whymitochondrial morphology became altered at
later time points after rerouting TPD54, we used EM to examine
the ultrastructure of mitochondria at different time points
(Fig. 5). Cells expressing MitoTrap and mCherry-FKBP-TPD54
were imaged as rapamycin was applied (Fig. 5 A). They were
then fixed at various times after rerouting, and the same cells
were then imaged by EM. The mitochondrial TPD54 signal was
partial 20 s after rapamycin; after 5 min the signal wasmaximal,
and after 30 min mitochondrial aggregation was observed by
light microscopy (Fig. 5, A and B). At the EM level, in cells where
TPD54 was rerouted, mitochondria were decorated with nu-
merous small vesicles. After 5 min or 30 min, it was clear that
mitochondria had become aggregated because the vesicles had
contacted more than one mitochondrial surface. We segmented
the mitochondrial and vesicular profiles to analyze this effect in
more detail (Fig. 5 C). The vesicles captured after TPD54 re-
routing are small, homogeneous (29.9 ± 9.4 nm), and do not
change size over time (Fig. 5, D and E). The number of vesicles
captured per unit length of mitochondrial perimeter increases
with time, and the perimeter lengths that remain undecorated
decreases (Fig. 5 E). We noted significant vesicle capture at the
Figure 3. Golgi dispersal in cells lacking TPD54. (A) Micrographs of TGN46 distribution in HeLa cells treated with siCtrl (GL2) or siTPD54 (TPD54 RNAi).
Scale bar, 10 µm. (B) Quantification of Golgi dispersal in control and TPD54-depleted cells. Golgi dispersal is the area of a convex hull of the TGN46 signal as a
fraction of the total cell area. ncell = 155−197, nexp = 3. Inset, Western blot to show knockdown efficiency. (C) Micrographs of TGN46 distribution in parental
HeLa cells and two clones with targeted disruption of the TPD54 locus (2.4 and 2.2). Scale bar, 10 µm. (D) Quantification of Golgi dispersal in each clone
compared with parental cells. FLAG-TPD54 and FLAG-TACC3 was expressed as indicated; − indicates no reexpression. Dots represent individual cells, boxes
show interquartile range, bars represents the median, and whiskers show 9th and 91st percentiles. ncell = 19−30, nexp = 3. The P values shown are from
Wilcoxon rank sum test (B) or Dunnett’s multicomparison test compared with control with no reexpression (D). KO, knockout.
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earliest time point we could study: 20 s after rapamycin. Mito-
chondria in control cells are essentially undecorated, with the
occasional vesicle coinciding with our detection criteria, con-
firming that vesicle capture is a result of TPD54 rerouting to
mitochondria. These experiments explain the mitochondrial
aggregation and suggest that TPD54 is resident on a large pop-
ulation of small-size intracellular vesicles. Because of their size
and lack of coat, these vesicles are unlike any formerly described
class of vesicle. We refer to them as INVs.
Visualizing INVs by light microscopy
TPD54 localizes to a small number of large puncta in cells, with
the remainder being apparently cytoplasmic (Fig. 1 A). Could it
be that the “cytoplasmic” TPD54 actually corresponds to a large
population of small TPD54-positive vesicles (INVs) that are be-
low the resolution limit of the microscope? In support of this
idea, close inspection of our previous live-cell imaging data
showed that the cytoplasmic TPD54 signal flickered as expected
for mobile subresolution vesicles (for example, see Video 3 be-
fore rapamycin addition). To quantify this flickering behavior,
we used the spatiotemporal variance of fluorescence in live-cell
imaging videos. Indeed, the variance was over twofold greater in
cells expressing GFP-TPD54 (either overexpressed or endoge-
nous) compared with GFP, which has a uniform cytosolic dis-
tribution (Fig. 6, A and B; and Video 4). Moreover, FRAP analysis
showed slower kinetics for GFP-TPD54 compared with GFP,
which rapidly recovers as a freely diffusing cytosolic protein.
We could only detect a minimal freely diffusing pool of TPD54
under conditions of overexpression (summarized in Fig. S4;
examples in Video 5). These results are consistent with GFP-
TPD54 being absent from the cytosol, but predominantly local-
ized on small vesicles that are below the resolution limit.
To unambiguously visualize these subresolution structures,
we used stochastic optical reconstruction microscopy (STORM)
to image endogenous TPD54 in GFP-TPD54 knock-in HeLa cells
(Fig. 6, C–G). The reconstructed single-molecule localization
microscopy images showed that the subresolution structures
are, in fact, small puncta (Fig. 6, C–E). These spots had an av-
erage width of 33.6 nm, which agrees with the size of INVs
observed by EM (Fig. 6 G). They were also as numerous as the
vesicle capture experiment suggested, with an average density
of 26.8 spots per 10 µm2. Together these data indicate that
TPD54 is resident on INVs and that these vesicles are not the
product of the vesicle capture procedure, but are normally found
in cells.
INVs meet three criteria for functionality
The small size of INVs raised the question of whether or not they
were functional. We reasoned that there are three basic criteria
for a vesicle to be considered functional: it must (1) contain
Figure 4. TPD54 can be rerouted efficiently to mitochondria. (A) Confocal micrographs showing the rerouting of mCherry-FKBP-TPD54, but not mCherry-
TPD54, to mitochondria in cells coexpressing YFP-MitoTrap after addition of 200 nM rapamycin (orange bar). (B) Kinetics of mCherry-FKBP-TPD54 rerouting.
The mitochondrial and cytoplasmic signal of mCherry-FKBP-TPD54 as a function of time after the addition of 200 nM rapamycin at 10 s. Line and shaded area
show the mean ± SEM, ncell = 16. (C) Still images from a TPD54 rerouting video. Time, minutes and seconds (rapamycin at 0:10). Insets, 2× zoom. Scale bars,
10 µm, 1 µm (inset).
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cargo, (2) have fusion machinery, and (3) associate with a Rab
GTPase.
We first sought to identify the vesicles’ cargo. To do this, we
tested five model cargoes where the α chain of CD8 is fused
to different peptides that bear various endocytic motifs (Kozik
et al., 2010). Briefly, CD8-FANPAY, CD8-YAAL, or CD8-EAAALL
has a single [F/Y]XNPX[Y/F], YXXϕ, or [D/E]XXXL[L/I/M]
motif, respectively (where X is any amino acid and ϕ is a hy-
drophobic amino acid). CD8-CIMPR has the tail of the cation-
independent mannose-6-phosphate receptor (CIMPR), which
contains at least four endocytic motifs, including two of the di-
leucine type. As a control, CD8-8xA was used, which has eight
alanines and no endocytic motif and therefore cannot be inter-
nalized. We examined the subcellular distribution of these car-
goes in cells where TPD54 had been rerouted tomitochondria. In
the control condition with no addition of rapamycin, all CD8
constructs were in endosomes or, in the case of CD8-8xA, at the
PM. After rerouting, the localization of CD8-8xA, CD8-FANPAY,
Figure 5. Capture of small vesicles by rerouting TPD54 tomitochondria. (A) Fluorescencemicroscopy images of mCherry-FKBP-TPD54 in HeLa cells. Cells
expressing mCherry-FKBP-TPD54 and dark MitoTrap were fixed after no rapamycin application (Ctrl) or after 20 s, 5 min, or 30 min of rapamycin addition (200
nM). The pictured cell was then imaged by EM. Scale bar, 10 µm. (B) Sample electron micrographs of the cells shown in A. Insets, 3× zoom. Scale bars, 200 nm,
50 nm (insets). (C) Segmented view of mitochondria (gray) and vesicles (purple) in the images shown in B. (D) Profiles of segmented vesicles from electron
micrographs. All vesicles segmented from the control dataset are shown with a random sample from the treatment groups as a comparison. The sample size is
in proportion to the capture of vesicles at the mitochondria (34, 320, 594, and 1,347 for control, 20 s, 5 min, and 30 min, respectively). (E) Left: violin plot to
show the diameter of vesicles imaged in each dataset. Spots represent individual vesicles. Marker shows the median. Center: box plot to show the number of
vesicles captured per 1 µm of mitochondrial membrane. Spots show the number per micrograph in each dataset. Boxes show the interquartile range and
median, and whiskers show 9th and 91st percentiles. Right: violin plot to show the fraction of mitochondrial membrane that is decorated with vesicles. Spots
show individual mitochondria from the dataset. Time, minutes and seconds. See Materials and methods for details.
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and CD8-YAAL was unaffected, whereas CD8-EAAALL and CD8-
CIMPR were co-rerouted with TPD54 to the mitochondria (Fig. 7
A). To ensure that this co-rerouting was genuine and not a pe-
culiarity of the model cargoes, we confirmed that endogenous
CIMPR also co-rerouted with TPD54 (Fig. 7 B). This suggested
that vesicles with cargo harboring a dileucine motif were pref-
erentially captured by TPD54 rerouting.
Having captured specific cargo that is present in INVs at
steady-state, we next tested if INVs were actively trafficking
cargo. Receptors containing dileucine endocytic motifs are in-
ternalized at the PM and then recycled via either recycling
endosomes or the Golgi apparatus. We therefore labeled
CD8-EAAALL at the surface with Alexa Fluor 488–conjugated
anti-CD8 antibodies, allowed internalization and trafficking to
proceed, and, at different time points, performed mitochondrial
vesicle capture via TPD54 rerouting (Fig. 7 C). Capture of
surface-labeled CD8-EAAALL occurred at time points >60 min
after internalization (Fig. 7 D). These experiments indicate that
dileucinemotif–containing receptors transit via INVs, which can
be captured on mitochondria by TPD54 rerouting, but only at
late time points after internalization. The time course of capture
is consistent with recycling of endocytic cargo from the Golgi
apparatus.
The second criterion for vesicle functionality is whether the
vesicles contain the machinery for fusion. Accordingly, we
tested for co-rerouting of endogenous SNAREs in our vesicle
capture assay. Generally, vesicle-resident R-SNAREs, but not
target membrane-resident Q-SNAREs, were co-rerouted with
TPD54 tomitochondria.We found co-rerouting of the R-SNAREs
VAMP2, VAMP3, VAMP7, and VAMP8, but not the Q-SNAREs
STX6, STX7, STX8, STX10, or STX16 (Fig. 8). There was some
evidence of selectivity with the localization of the R-SNARE
VAMP4 being unaffected by TPD54 rerouting. Moreover, the
presence of different SNAREs suggests that although the cap-
tured INVs appear morphologically homogeneous, they are
likely to be a crowd of different vesicle identities.
What are the identities of the vesicles captured by TPD54
rerouting? To answer this question, we screened 43 GFP-tagged
Rab GTPases for co-rerouting with mCherry-FKBP-TPD54 to
dark MitoTrap. The collection of GFP-Rabs tested covers a range
of membrane trafficking pathways (Yoshimura et al., 2007;
Zhen and Stenmark, 2015; Wandinger-Ness and Zerial, 2014).
The results of the screen are presented in Fig. 9, with examples
of positive and negative hits shown in Fig. S5 A. This screen
confirmed that INVs meet the third criterion for functionality:
being associated with specific Rabs.
INVs have a heterogeneous complement of Rab GTPases
In the vesicle capture screen, significant co-rerouting was de-
tected for 16 out of 43 Rabs. These positive hits were Rab30,
Rab25, Rab26, Rab45, Rab14, Rab11a, Rab12, Rab1a, Rab43, Rab1b,
Rab10, Rab33b, Rab19, Rab33a, Rab37, and Rab2a (listed by de-
scending effect size; Fig. 9 C). Some evidence for co-rerouting of
Rab38, Rab5c, and Rab35 was seen, although in any individual
trial no clear difference was observed. The localization of the
other 24 Rabs was unaffected by rerouting of TPD54 and was
indistinguishable from GFP. Rab30 was the most efficiently
Figure 6. Visualizing INVs by light microscopy. (A) Single ROIs from
live-cell imaging experiments with cells expressing GFP or GFP-TPD54
(overexpressed [OE]), or with knock-in GFP-TPD54 cells (endo). Images are
pseudocolored to highlight subresolution structures. Scale bar, 1 µm.
(B) Scatter dot plot to show the mean variance per pixel over time. Dots,
individual cells; black bars, mean ± SD. The mean ± SD for GFP is indicated as
a thin black line and gray zone. ncell = 16–20. (C) TIRF image showing the
ventral surface of a typical GFP-TPD54 knock-in HeLa cell imaged by STORM.
Scale bar, 10 µm. (D) Expanded view of the boxed region in C. Scale bar, 500
nm. (E) STORM image of the corresponding region shown in D. Localizations
are pseudocolored as indicated; max value in image was 79. Scale bar, 500
nm. (F) Histogram of FWHM values of all spots in the entire localizations
image for the cell shown in C. (G) Summary of median FWHM values. Bars,
mean ± SD. ncell = 5, nexp = 3.
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co-rerouted Rab, with the post-rerouting signal being 2.5-fold
higher than before TPD54 rerouting (Video 6). The smallest
effect that we could reliably detect was Rab2a, with a 1.4-fold
increase. In the case of Rab1a, we confirmed that co-rerouting
was also seen with the endogenous protein (Fig. S5 B).
If the relocalization of Rabs observed in the screen was the
result of co-rerouting with TPD54, a correlation between the ex-
tent of rerouting for a Rab and TPD54 is predicted (Fig. 9 D). This
was broadly true, with a positive correlation observed for almost
all of our positive hits, and a low, flat relationship for negative
Rabs. Rab14was an exception. Here, the relationshipwas high and
flat; Rab14 rerouting was maximal even after modest TPD54 re-
routing. This result is consistent with there being a very limited
pool of Rab14-positive vesicles, all of which are TPD54 positive.
We next performed a test of reciprocality by asking if
mCherry-TPD54 was co-rerouted to mitochondria when a GFP-
FKBP-Rab was rerouted to dark MitoTrap using 200 nM rapa-
mycin. We tested two positive hits from our screen, Rab11a and
Rab25, as well as a negative, Rab7a (Fig. S5 C). Rerouting of
either Rab11a or Rab25 caused co-rerouting of TPD54, while
rerouting Rab7a to mitochondria had no effect on TPD54 local-
ization. Interestingly, we noticed that when Rab11a or Rab25
was rerouted, there was still a number of TPD54-positive
structures, presumably associated with other Rabs, that were
not rerouted (Fig. S5 C). TPD54 rerouting tended to give a more
complete removal of Rab-positive structures from the cytoplasm
(Fig. S5 A). This observation supports the idea that TPD54 de-
fines a class of vesicle that each bears a Rab from a large subset
of Rab GTPases. The collective heterogeneity of Rabs and
R-SNAREs on INVs suggests that this class of transport vesicle
has diverse origins and varied destinations. The summary in
Fig. 10 shows the results from the Rab screen on a cellular map
Figure 7. TPD54 co-reroutes dileucine motif-containing receptors only. (A) Representative widefield micrographs of cells coexpressing mCherry-FKBP-
TPD54, dark MitoTrap, and the indicated CD8 construct. Rerouting was induced by 200 nM rapamycin. Cells were fixed, permeabilized, and stained for total
CD8. (B) Representative widefield micrographs showing co-rerouting of endogenous CIMPR detected by immunofluorescence with rerouting of mCherry-
FKBP-TPD54 to dark MitoTrap by addition of 200 nM rapamycin. (C) Pulse label and timed vesicle capture experiments. Cells expressing CD8-EAAALL were
surface labeled with Alexa Fluor 488–conjugated anti-CD8 antibodies for 30 min, then incubated at 37°C for the indicated time (minutes), treated with 200 nM
rapamycin for 5 min, and fixed. (D) Representative widefield micrographs from a pulse label and timed vesicle capture experiment. Inset, 5× zoom. Scale bars,
10 µm, 1 µm (insets). Time, hours and minutes.
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of intracellular trafficking pathways. Several pathways are
“ruled out” due to their governance by Rabs which were nega-
tive in our screen. Positive hits coincide with anterograde or
recycling pathways and with Golgi transport, which is in
agreement with our functional data on the function of TPD54.
Our proposed model for INVs, therefore, is that they represent a
generic class of transport vesicle that is found throughout much
of the membrane traffic network.
Discussion
This study shows that TPD54, an abundant protein in mamma-
lian cells, is found on numerous small vesicles throughout the
cell. These vesicles—INVs—are functional since they have
cargo, fusion machinery, and Rabs. The heterogeneity of Rabs
and SNAREs suggests that INVs are generic transport carriers
that mediate transport between diverse originating membranes
and various destinations. Accordingly, we saw that loss of TPD54
interferes with several membrane traffic steps: anterograde
traffic, recycling, and Golgi integrity.
We found INVs serendipitously. Using a knocksideways-
based system, when TPD54 was rerouted to mitochondria, we
saw that it was associated with small vesicles. There have been
previous reports of vesicle capture at mitochondria following
knocksideways of gadkin (Hirst et al., 2015), or by ectopic mi-
tochondrial expression of Golgins (Wong and Munro, 2014).
However, the vesicles captured by rerouting TPD54 are smaller:
29.9 ± 9.4 nm in diameter. Vesicles of a similar size distribution
were also observed under normal conditions by STORM imag-
ing. Few types of vesicles are this small. For example, clathrin-
coated vesicles are 50–100 nm, COPII-coated vesicles are 60–70
nm, and intra-Golgi transport vesicles are 70–90 nm (Vigers
et al., 1986; Balch et al., 1994; Orci et al., 2000). Synaptic vesi-
cles are a good size match at 33–38 nm, but they are restricted to
Figure 8. Co-rerouting of R-SNARES, but not Q-SNARES, with TPD54. Representative confocal micrographs showing the co-rerouting of SNAREs as
indicated after TPD54 rerouting to mitochondria. SNAREs were detected by immunofluorescence, with the exception of VAMP2, which is coexpressed as GFP-
VAMP2 (widefield image). Insets, 3× zoom. Scale bars, 10 µm, 1 µm (insets).
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neurons (Harris and Sultan, 1995). In nonneuronal cells, the
closest-sized vesicles are intralumenal vesicles, which range
from 20 to 100 nm (Edgar et al., 2014; Raposo and Stoorvogel,
2013). However, their inaccessibility and opposite orientation
makes intralumenal vesicles an unlikely candidate for the
vesicles captured by TPD54 rerouting. Our interpretation is that
INVs are an overlooked class of intracellular vesicle. With no
coat to distinguish them and with an unimposing size, these
inconspicuous vesicles seem to have evaded study until now.
Is it possible that TPD54 is on a wider variety of vesicles, but
that rerouting only captures the smallest of all TPD54-positive
vesicles? One could imagine that smaller vesicles are captured
more efficiently than larger ones. However, larger vesicles and
even Golgi cisternae can be captured by mitochondria under
different experimental conditions (Hirst et al., 2015; Wong and
Munro, 2014; Shin et al., 2017; Dunlop et al., 2017), suggesting
that TPD54 is predominantly localized to these small vesicles and
that this is the reason why they are captured more efficiently.
Moreover, it is unlikely that the captured vesicles are the result
of vesicularization of larger membranes since we saw the cap-
ture of 30 nm vesicles after only 20 s of TPD54 rerouting and no
further change in size of captured vesicles at longer time points.
In addition, super-resolution imaging also showed only small
puncta.
INVs appear to be real, functional transport carriers because
the vesicles we captured had cargo, fusion machinery, and Rabs.
There was selectivity in their cargo, which all featured
dileucine-type endocytic motifs (Bonifacino and Traub, 2003),
and in their R-SNARE complement. The presence of SNAREs in
INVs could be determined by their dileucine sorting motifs, al-
though we saw no co-rerouting of VAMP4, which has one such
motif (Peden et al., 2001; Gordon et al., 2009). How the cargo
and SNAREs are sorted into INVs is an interesting question for
future investigation, as is the broader question of how they bud.
Our rerouting assay reports which proteins were passengers in
INVs, but does not tell us which of these, if any, TPD54 binds
Figure 9. A screen to identify Rab GTPases that are associated with TPD54. (A) Quantification of the change in mitochondrial fluorescence intensity of
GFP or GFP-Rabs 2 min after rerouting of mCherry-FKBP-TPD54 to dark MitoTrap with 200 nM rapamycin. Multiple independent experiments were completed
(dots) across three independent trials. Black bars, mean ± SD. The mean ± SD for GFP (control) is also shown as a black line and gray zone, down the plot.
Dunnett’s post-hoc test was done for each trial using GFP as a control. Colors indicate if P < 0.05 in one, two, or three trials, or only when all the data were
pooled. ncell = 17–36, nexp = 3. (B) Effect size and bootstrap 95% confidence interval of the data in A. (C) The plot in B is reordered to show Rabs ranked in order
of highest to lowest effect size. (D) Small multiple plots show the correlation between the mCherry-FKBP-TPD54 rerouting and GFP-Rabs co-rerouting (gray
dots), a line fit to the data (black), and a y = x correlation (white).
Figure 10. Cellular localization of INVs. Schematic diagram showing the cellular pathways on which the Rab GTPases operate. Rabs are represented by their
number. Red and gray numbers indicate positive and negative Rab hits, respectively. Red and black arrows indicate pathways that involve a Rab that is a
positive hit or where only negative hits were found, respectively. INVs are shown as purple vesicles peppered throughout most, but not all, of the network. The
inset summarizes the three types of protein found on INVs that were tested in the present study.
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directly. In the case of Rab GTPases, we found that Rab2a, Rab5c,
and Rab14 co-immunoprecipitate with TPD54. Rab2a and Rab14
were positive hits in our screen, while Rab5c was a borderline
hit. It is possible that TPD54 binds to these Rabs as an effector.
Previous work indicates that TPD52-like proteins can bind
Rabs. Rab5c was identified as a binding partner for TPD52
(Shahheydari et al., 2014), and an indirect association of Rab5,
Rab6, and Rab9 with TPD52 has also been reported (Zhang et al.,
2007), although Rab5a, Rab6, and Rab9 were all negative in our
screen using TPD54. Recently, MitoID was used to identify Rab
interactors, and TPD54 was not a top ranked hit for any of the
Rabs tested (Gillingham et al., 2019). Considering this and the
observation that at least 16 Rab GTPases from three different Rab
subgroups co-reroute with TPD54, it would seem unlikely that
TPD54 binds them all (Klo¨pper et al., 2012). We note that OCRL1
binds to multiple Rabs (six Rabs from four different subgroups)
via a single domain of 123 residues (Hou et al., 2011). Our
working model is that TPD54 can bind directly to INVs; inter-
actions with Rabs are possible but not necessary for INV
localization.
The generation of small-size vesicles makes a lot of sense for
a transport network. Just as bicycle couriers are the fastest
physical delivery agents in crowded cities, small vesicles should
be able to rapidly access the most congested parts of cells to
deliver their cargo. For example, when cargo is recycled to the
PM, much attention has been focused on large tubules that
emerge from the sorting endosome (Geuze et al., 1983). How-
ever, analysis of the delivery of receptors at the cell surface
indicates that the final carrier is a small-size vesicle rather than
a large tubule (Xu et al., 2011; Shen et al., 2014). This raises the
possibility that INVs may bud from large secondary carriers as
well as from the primary originating organelle. While being
small has its advantages, a major disadvantage is that the ca-
pacity of INVs is restricted. Small vesicles can actually carry a
surprising amount of cargo (Takamori et al., 2006; Martins
Ratamero and Royle, 2019 Preprint), but they are presumably
restricted for the carriage of large cargo: i.e., those with bulky
extracellular domains or large ligands (Martins Ratamero and
Royle, 2019 Preprint), although not necessarily (McCaughey
et al., 2019). Other classes of vesicle exhibit size adaptability.
Clathrin-coated vesicles can vary in size (Miller et al., 2015), and
very large clathrin-coated vesicles can form in some prepara-
tions (Perry and Gilbert, 1979). Intralumenal vesicles become
larger after internalization of EGF, suggesting that cargo can
influence vesicle size (Edgar et al., 2014). Whether INVs show
similar adaptability as other vesicle classes, and under what
circumstances, remains to be tested.
Materials and methods
Molecular biology
GFP-TPD54, mCherry-TPD54, and FLAG-TPD54 were made by
amplifying TPD54 by PCR from human tumor protein D54
(IMAGE clone, 3446037) and inserted into either pEGFP-C1,
pmCherry-C1, or pFLAG-C1 via XhoI-MfeI. GFP-FKBP-TPD54
was made by ligating a XhoI-BamHI fragment from mCherry-
TPD54 into pEGFP-FKBP-C1. This plasmid was converted to
mCherry-FKBP-TPD54 by cutting at BamHI-MfeI and inserting
into pmCherry-C1.
YFP-MitoTrap and the CD8 chimeras were gifts from Scottie
Robinson (University of Cambridge, Cambridge, UK; Addgene,
#46942), and mCherry-MitoTrap was previously described
(Cheeseman et al., 2013; Addgene, #59352). The dark MitoTrap
(pMito-dCherry-FRB) has a K70N mutation in mCherry (Wood
et al., 2017).
The GFP-Rab constructs were a gift from Francis Barr
(University of Oxford, Oxford, UK), except for GFP-Rab1a and
GFP-Rab5c, which were made by amplifying human Rab1a or
Rab5c (Rab1a: Addgene, #46776; Rab5c: GeneArt synthesis) by
PCR and inserting the genes in pEGFP-C1 via SacI-KpnI. GFP-
FKBP-Rab11 and GFP-FKBP-Rab25 were a gift from Patrick
Caswell (University of Manchester, Manchester, UK), and
GFP-FKBP-Rab7a was made by inserting Rab7a in pEGFP-
FKBP-C1 via SacI-SalI.
The plasmid to express mCherry-OCRL1 was a gift from
Martin Lowe (University of Manchester). GalT-mCherry was
made by cutting GalT via BamHI and MfeI from GalT-CFP (gift
from Ben Nichols, MRC Laboratory of Molecular Biology, Cam-
bridge, UK) and inserting into pmCherry-N1. GFP-VAMP2 and
mCherry-VAMP2 were made by amplifying VAMP2 from syn-
aptopHluorin (gift from James Rothman, Yale School of Medi-
cine, New Haven, CT) and inserted into pEGFP-C1 or mRFP-C1
via HindIII and EcoRI. FLAG-TACC3 was made by amplifying
TACC3 (IMAGE clone, 6148176; GenBank accession no. BC106071)
by PCR and inserting into pFLAG-C1 via XmaI and MluI.
mCherry-LCa was made by pasting LCa into pmCherry-C1 via
BglII and EcoRI. SBP-EGFP–E-cadherin and APPL1-mCherry
were obtained from Addgene (#65292 and #27683, respectively).
Cell culture
HeLa cells (Health Protection Agency/European Collection of
Authenticated Cell Cultures, #93021013) were maintained in
DMEM supplemented with 10% FBS and 100 U/ml penicillin/
streptomycin at 37°C and 5% CO2. RNAiwas done by transfecting
100 nM siRNA (TPD54 #1, 59-GUCCUACCUGUUACGCAAU-39;
TPD54 #2, 59-CUCACGUUUGUAGAUGAAA-39; TPD54 #3, 59-
CAUGUUAGCCCAUCAGAAU-39; siCtrl, 59-CGTACGCGGAATACT
TCGA-39) with Lipofectamine 2000 (Thermo Fisher Scientific)
according to the manufacturer’s protocol. For DNA plasmids,
cells were transfected with a total of 300 ng DNA per well of a
4-well, 3.5-cm dish using 0.75 µl Genejuice (Merck Millipore)
following the manufacturer’s protocol. Cells were imaged 1 d
after DNA transfection and 2 d after siRNA transfection (RUSH
and recycling). For two rounds of RNAi (Golgi integrity), HeLa
cells were transfected with the TPD54-targeting siRNA for 48 h
and transfected again with the siRNA for an additional 72 h.
The GFP-TPD54 CRISPR knock-in HeLa cell line was gener-
ated by transfecting the Cas9n D10A nickase plasmid containing
the guide pairs (guide 1, 59-ACCGCTGTCGCGGGCGCTAT-39;
guide 2, 59-GCCCGAACATGGACTCCGC-39) and the repair tem-
plate. 9 d after transfection, GFP-positive cells were selected by
FACS and isolated. Clones were validated by Western blotting
and genome sequencing (sequencing primers: 59-CAGTTTCGG
CCTATCAGGTTGAGTC-39; 59-GAACCACACCTCGGAACGGTC-39;
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59-CAGCTTGTGCCCCAGGATGTTG-39; 59-CAACTACAAGACCCG
CGCCGAG-39).
The TPD54 knockout HeLa cell lines were generated by
transfecting the Cas9 plasmid containing one of the three guide
pairs (guide 1, 59-CACCGTCGCGGATTACGAAACGCCG-39; guide
2, 59-CACCGTTTCGTAATCCGCGATGCGA-39; guide 3, 59-CAC
CGACCGCTGTCGCGGGCGCTAT-39). The transfected cells were
selected with 1 mg/ml puromycin 24 h after transfection. Clones
were isolated and validated by Western blot and sequencing
genomic DNA.
Biochemistry
For Western blot analysis, the antibodies used were rabbit anti-
TPD54 (Dundee Cell Products) 1:1,000, mouse anti–α-tubulin
(Abcam, ab7291) 1:10,000, mouse anti-GFP clones 7.1 and 13.1
(Roche, 118144600010) 1:1,000, and mouse anti-clathrin heavy
chain TD.1 (hybridoma) 1:1,000.
For immunoprecipitations, two 10-cm dishes of confluent
HeLa cells expressing either GFP or GFP-TPD54 were used for
each condition (10 µg DNA transfected per 10-cm dish). Cells
were lysed in lysis buffer (10 mM Tris-HCl, pH 7.5, 150 mM
NaCl, 0.5 mM EDTA, 0.5% NP-40, and protease inhibitors;
Roche). The lysate was then incubated for 1 h with GFP-Trap
beads (ChromoTek) and washed once with exchange buffer
(10 mM Tris-HCl, pH 7.5, 150 mM NaCl, and 0.5 mM EDTA)
and three times with wash buffer (10 mM Tris-HCl,
pH 7.5, 500 mM NaCl, and 0.5 mM EDTA). The immuno-
precipitations were run on a 4–15% polyacrylamide gel until
they were 1 cm into the gel. The columns were then cut and
sent for mass spectrometry analysis to the FingerPrints Pro-
teomics Facility (University of Dundee, Dundee, UK). Protein
scores from four experiments were used to make the volcano
plot in IgorPro.
Immunofluorescence
HeLa cells grown on coverslips were fixed at RT with 3% par-
aformaldehyde, 4% sucrose in PBS for 15 min, and per-
meabilized at RT in 0.1% saponin for 10 min (for all staining,
unless stated otherwise). For LAMP1 staining, cells were fixed
and permeabilized with ice-cold methanol at −20°C for 10 min.
For CD8, TGN46, EEA1, Rab1a, CIMPR, and FLAG staining, cells
were fixed in 3% paraformaldehyde, 4% sucrose in PBS for
15 min, and permeabilized at RT in 0.5% Triton-X100 in PBS for
10 min. Cells were then blocked in 3% BSA in PBS for 1 h. Cells
were incubated for 1 h at RT, with primary antibodies used as
follows: mouse anti-EEA1 (BD Biosciences, 610457) 1 µg/ml,
rabbit anti-LAMP1 (Cell Signaling, 9091) 1:200, sheep anti-
TGN46 (AbD Serotec, AHP500G) 1.25 µg/ml, mouse anti-CD8
(Bio-Rad, MCA1226GA) 10 µg/ml, rabbit anti-Rab1a (Cell Sig-
naling, D3X9S) 0.8 µg/ml, rabbit anti-CIMPR (Thermo Fisher
Scientific, PA3-850) 1:500, and mouse anti-FLAG M2 (Sigma,
F1804) 1 µg/ml. Anti-SNARE antibodies were a gift from An-
drew Peden (University of Sheffield, Sheffield, UK): rabbit anti-
VAMP3 (1:200), rabbit anti-VAMP4 (1:500), rabbit anti-VAMP7
(1:50), rabbit anti-VAMP8 (1:100), rabbit anti-STX6 (1:200),
rabbit anti-STX7 (1:400), rabbit anti-STX8 (1:100), rabbit anti-
STX10 (1:50), and mouse anti-STX16 (1:200), described in
Gordon et al. (2010). Cells were washed three times with
PBS for 5 min and incubated for 1 h at RT with Alexa Fluor
(Invitrogen) secondary antibodies. To co-reroute the CD8-EAAALL
chimera after timed incubation with anti-CD8 antibodies, cells
were labeled with 10 µg/ml Alexa Fluor 488–conjugated anti-
CD8 antibodies (AbD Serotec, MCA1226A488) at 4°C for 30 min.
Cells were then incubated at 37°C in warm growth medium for
the indicated time points. Rerouting was done by adding 200
nM rapamycin at 37°C. Cells were fixed and mounted after
5 min, as described above.
For STORM, the samplewas prepared as described in Jimenez
et al. (2019). GFP-TPD54 knock-in CRISPR HeLa cells were fixed
for 10 min at 37°C in prewarmed fixation buffer (4% formalde-
hyde, 4% sucrose, 80 mM Pipes, 5 mM EGTA, and 2 mMMgCl2,
pH 6.8). Cells were then washed three times with PBS, per-
meabilized, and blocked at the same time for 1 h at RT in
blocking buffer (0.22% gelatin from bovine skin type B, 0.1%
Triton-X100, and PBS). Anti-GFP polyclonal primary antibodies
(Invitrogen, A-11122) were diluted in blocking solution (10 µg/
ml) and applied for 2.5 h at RT. The cells were washed three
times for 10 min at RT in blocking solution with gentle agitation
and incubated with Alexa Fluor 647–conjugated secondary an-
tibodies for 1 h at RT. Cells were washed three times for 10 min
in blocking solution with agitation at RT and brought directly to
the microscope for STORM.
For the transferrin assay, HeLa cells grown on coverslips
were serum starved for 30 min at 37°C, and then incubated at
4°C for 30 min with 25 µg/ml of Alexa Fluor 488–conjugated
transferrin (Thermo Fisher Scientific, 11550756). The coverslips
were then dipped in distilled H2O, placed in warm growth me-
dium, and incubated at 37°C for 5–75 min to allow internaliza-
tion and recycling before fixation.
Confocal microscopy
Cells were grown in 4-well, glass-bottom, 3.5-cm dishes
(Greiner Bio-One), and media were exchanged for Leibovitz
L-15 CO2-independent medium for imaging at 37°C on a spin-
ning disc confocal system (Ultraview Vox, PerkinElmer) with a
100× 1.4 NA oil-immersion objective. Images were captured
using an ORCA-R2 digital charge-coupled device camera (Ha-
mamatsu) following excitation with 488-nm and 561-nm lasers.
For the RUSH assay, SBP-EGFP–E-cadherin was released from
the ER by adding a final concentration of 40 µM D-Biotin
(Sigma) in Leibovitz L-15 medium. Images were captured at
an interval of 2 min. Rerouting of mCherry-FKBP-TPD54 to the
mitochondria (dark MitoTrap) was induced by addition of 200
nM rapamycin (Alfa Aesar). Rerouting kinetics experiments
were measured by recording videos of 150 s (1 frame per sec-
ond), where rapamycin is added after 10 s. The kinetics of
mCherry-FKBP-TPD54 rerouting to mitochondria was similar
in cells with or without depletion of endogenous TPD54. For the
Rab GTPase co-rerouting experiments, an image before rapa-
mycin and an image 2 min after rapamycin were taken of live
cells. For the FRAP experiment, a cytoplasmic region of 6.69 µm
× 10.76 µm was bleached using a 488-nm laser for five cycles of
100 ms. Images were captured at the highest frame rate pos-
sible (0.1775 s).
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Correlative light-EM
Following transfection, cells were plated onto gridded dishes
(P35G-1.5-14-CGRD, MatTek). Light microscopy was done using
a Nikon Ti epifuorescence microscope, a heated chamber
(OKOlab), and a CoolSnap MYO camera (Photometrics) using
NIS-Elements AR software. During imaging, cells were kept at
37°C in Leibovitz L-15 CO2-independent medium supplemented
with 10% FBS. Transfected cells were found, and the grid coor-
dinate containing the cell of interest was recorded at low mag-
nification. Live-cell imaging was done on a cell-by-cell basis at
100×. During imaging, 200 nM (final concentration) rapamycin
was added for variable times before the cells were fixed in 3%
glutaraldehyde and 0.5% paraformaldehyde in 0.05 M phos-
phate buffer, pH 7.4, for 1 h. Aldehydes were quenched in 50mM
glycine solution and thoroughly washed in H2O. Cells were post-
fixed in 1% osmium tetroxide and 1.5% potassium ferrocyanide
for 1 h and then in 1% tannic acid for 45 min to enhance mem-
brane contrast. Cells were rinsed in 1% sodium sulfate and then
twice in H2O before being dehydrated in grade-series ethanol
and embedded in EPON resin (TAAB). The coverslip was re-
moved from the polymerized resin, and the grid was used to
relocate the cell of interest. The block of resin containing the cell
of interest was then trimmed with a glass knife, and serial 70-
nm ultrathin sections were taken using a diamond knife on an
EM UC7 (Leica Microsystems) and collected on formvar-coated
hexagonal 100mesh grids (EM Resolutions). Sections were post-
stained with Reynolds lead citrate for 5 min. Electron micro-
graphs were recorded using a JEOL 1400 transmission EM
operating at 100 kV using iTEM software.
STORM
STORM was performed using a custom-built total internal
reflection fluorescence (TIRF) widefield microscope with en-
hanced stability (Huang et al., 2016) with a 100× 1.49 NA oil-
immersion objective and Andor iXon X3 camera controlled by
μManager. Cells were placed between two coverslips, and
STORM buffer (50 mM Tris, pH 8, 10 mM NaCl, 10% glucose,
50 mM cysteamine [Sigma, 60–23-1], 0.5 mg/ml glucose
oxydase [Sigma, G2133], and 40 µg/ml catalase [Sigma, C40])
was added to the cells (Jimenez et al., 2019). A TIRF image was
acquired, followed by a STORM acquisition. 12,000 images
(60-ms exposure time) were acquired with the 647-nm laser.
Fluorophores were reactivated during imaging by increasing
illumination with a 405-nm laser every 20 frames. The
STORM images were reconstructed using the Fiji plugin GDSC
single-molecule localization microscopy (Schindelin et al.,
2012).
Image analysis
For analysis of RUSH videos, a region of interest (ROI) was
drawn around the cell and around the Golgi apparatus in Fiji.
The area, mean pixel intensity, and integrated density were
measured from these ROIs to get fluorescence intensity ratios.
Data were processed in IgorPro using custom scripts. Briefly, a
logistic function (Eq. 1) was fitted to the data using the start of
the video and two frames after the maximum value as limits for
the fit:
f (x)  y0 + (ymax − y0)
1 + x1/2x n . (1)
The value for x1/2 in minutes was used for the t1/2 for ER-to-
Golgi. The corresponding y value for x1/2 was used to find the t1/2
for ER-to-PM. A line of best fit from ymax to the end of the trace
was found using f(x) = a + bx, and the y value corresponding to
x1/2 was found. The Golgi transit time is taken from the differ-
ence between the two t1/2 values.
Rerouting kinetics was quantified by averaging the pixel
intensity of 10 ROIs of 10 × 10 pixels on mitochondria and four
ROIs of varying size in the cytoplasm per cell throughout the
duration of the videos. The images were corrected for photo-
bleaching using the simple ratio method before measuring pixel
intensity for all ROIs. The intensity and time data were fed into
IgorPro, and a series of custom-written functions processed
the data.
For vesicle capture analysis, electron micrographs were
manually segmented in IMOD software using a stylus by a sci-
entist blind to the experimental conditions. The coordinates
corresponding to contours and objects were fed into IgorPro
using the output from model2point. All coordinates were scaled
from pixels to real-world values, and the vesicle diameters were
calculated using the average of the polar coordinates around the
vesicle center for each vesicle, along with other parameters. As a
metric for vesicle capture, the length of the mitochondrial pe-
rimeter was measured and used to express the vesicle abun-
dance per image (vesicles per 1 µm). The intersection of an area
corresponding to the vesicles, dilated by 15 nm and the mito-
chondrial perimeter, was used to express the fraction of mito-
chondrial perimeter that was decorated with vesicles. Analysis
of “flicker” in live-cell videos was done using 50 × 50-pixel
excerpts of 30 frames from live-cell imaging captured at
0.1775 s per frame. Each frame was first normalized to the mean
pixel intensity for that frame, and then the variance per pixel
over time was calculated, resulting in a 50 × 50 matrix of var-
iances. The mean of this matrix is presented as the metric of
flicker for that cell.
For unbiased estimation of INVs in STORM images, the xy
coordinates of spots in an image of localizations were logged
using “Find Maxima” in Fiji (prominence >5). The localizations
image and the coordinates were brought into IgorPro, and a 2D
Gaussian function (Eq. 2) was fitted to a 41 × 41-pixel image
centered on each coordinate:
f (x, y)  z0 + Aexp
"
−
 
(x − x0)2
2σ2x
+ (y − y0)
2
2σ2y
!#
. (2)
The spot width was taken as the full-width half-maximum
(FWHM; Eq. 3):
FWHM  2
ﬃﬃﬃﬃﬃﬃﬃﬃﬃ
2ln2
p
σy. (3)
For the Rab screen, co-rerouting of Rab GTPases was quan-
tified by averaging for each cell the pixel intensity in the green
channel in 10 ROIs of 10 × 10 pixels on the mitochondria, before
and after rapamycin. This mitochondrial intensity ratio (Fpost/
Fpre) for every Rab was compared with the ratio of GFP in
TPD54-rerouted cells. Estimation statistics were used to
Larocque et al. Journal of Cell Biology 14
New small transport vesicles defined by TPD54 https://doi.org/10.1083/jcb.201812044
D
ow
nloaded from
 https://rupress.org/jcb/article-pdf/219/1/e201812044/840661/jcb_201812044.pdf by guest on 17 D
ecem
ber 2019
generate the difference plot shown in Fig. 9 B. The mean dif-
ference is shown together with bias-corrected and accelerated
95% confidence intervals calculated in R using 1 × 105 bootstrap
replications.
For FRAP analysis, an ImageJ macro was used to define and
measure the GFP intensity (mean pixel density) in the FRAP
region, background, and whole cell. These data and time stamps
from the open microscopy environment were fed into IgorPro
for processing. The background-subtracted intensities for the
FRAP region and whole cell were used to calculate a ratio (to
correct for bleaching of molecules induced by the procedure).
These values were paired with the time stamps and scaled so
that the intensity after bleach was 0 and an average of the first
five images was 1, and then an interpolated average was created.
Fits to individual traces were also calculated using a script.
Double exponential function was used for fitting, since this gave
better fits than a single exponential, particularly for GFP-TPD54,
and so that all conditions were fitted in the same way for
comparison.
All figures were made with either Fiji or Igor Pro 8 (Wave-
Metrics) and assembled using Adobe Illustrator.
Data and software availability
The data for proteomics, volcano plot, FRAP data, and EM seg-
mentation coordinates are available, together with code and
scripts for analysis, at https://doi.org/10.5281/zenodo.3366083
(Royle, 2019).
Online supplemental material
Fig. S1 shows the characterization of the GFP-TPD54 knock-in
cell line. Fig. S2 demonstrates the localization of mCherry-
TPD54 in HeLa cells. Fig. S3 shows the characterization of
TPD54 knockout cell lines. Fig. S4 shows FRAP analysis of GFP
and GFP-TPD54. Fig. S5 shows the co-rerouting of Rab GTPases
with TPD54, the co-rerouting of endogenous Rab1a, and the co-
rerouting of TPD54 with Rab GTPases. Videos 1 and 2 show SBP-
EGFP–E-cadherin RUSH imaging in control or TPD54-depleted
cells, respectively. Video 3 demonstrates rerouting of mCherry-
FKBP-TPD54 to mitochondria. Video 4 shows imaging of sub-
resolution vesicle fluorescence. Video 5 demonstrates FRAP of
GFP or GFP-TPD54. Video 6 shows co-rerouting of a GFP-Rab
with mCherry-FKBP-TPD54.
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